Loading...
MEI Pharma, Inc.
MEIP•NASDAQ
Healthcare
Biotechnology
$2.69
$0.24(9.80%)
MEI Pharma, Inc. (MEIP) Financial Performance & Statements
Review MEI Pharma, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
33.76%
↑ 33.76%
Operating Income Growth
139.55%
↑ 139.55%
Net Income Growth
155.84%
↑ 155.84%
Operating Cash Flow Growth
3.83%
↑ 3.83%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-127.24%
↓ 127.24%
ROIC
-171.73%
↓ 171.73%
MEI Pharma, Inc. (MEIP) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for MEI Pharma, Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $3.78M | $86000.00 |
| Gross Profit | $0.00 | $0.00 | -$3.78M | -$86000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $308000.00 | $3.16M | $3.94M | $5.22M |
| SG&A Expenses | $3.14M | $5.19M | $4.14M | $4.52M |
| Operating Expenses | $3.45M | $8.35M | $7.96M | $9.74M |
| Total Costs & Expenses | $3.45M | $8.35M | $18.98M | $9.83M |
| Interest Income | $279000.00 | $355000.00 | $608000.00 | $706000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $368000.00 | $125000.00 | $86000.00 |
| EBITDA | -$3.45M | -$8.35M | -$7.74M | -$9.74M |
| EBITDA Ratio | ||||
| Operating Income | -$3.45M | -$8.35M | -$18.98M | -$9.83M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $774000.00 | $345000.00 | $574000.00 | $702000.00 |
| Income Before Tax | -$2.68M | -$8.007M | -$18.41M | -$9.13M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.68M | -$8.007M | -$18.41M | -$9.13M |
| Net Income Ratio | ||||
| EPS | -$0.40 | -$1.20 | -$2.76 | -$1.37 |
| Diluted EPS | -$0.40 | -$1.20 | -$2.76 | -$1.37 |
| Weighted Avg Shares Outstanding | $6.66M | $6.66M | $6.66M | $6.66M |
| Weighted Avg Shares Outstanding (Diluted) | $6.66M | $6.66M | $6.66M | $6.66M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan